Literature DB >> 20606299

Inhibition of L-type amino acid transporter modulates the expression of cell cycle regulatory factors in KB oral cancer cells.

Chun Sung Kim1, In-Sung Moon, Ju-Hyun Park, Woo-Cheol Shin, Hong Sung Chun, Sook-Young Lee, Joong-Ki Kook, Heung-Joong Kim, Joo-Cheol Park, Hitoshi Endou, Yoshikatsu Kanai, Byung-Kwon Lee, Do Kyung Kim.   

Abstract

The purpose of this study was to examine the effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), an inhibitor of L-type amino acid transporters, on the cell growth suppression in KB human oral cancer cells and to study the roles of cell cycle regulatory factors in the BCH-induced growth inhibition. The effect of BCH on cell growth suppression and the influence of BCH to cell cycle regulatory factors in KB cell growth inhibition were examined using cell cycle analysis, immunoblotting and immunoprecipitation. The BCH treatment induced cell cycle arrest at G1 phase in KB cells. The expression of cyclin D3 was remarkably decreased by BCH treatment. The BCH inhibited the expression of cyclin-dependent protein kinase 6 (CDK6) in a time-dependent manner. In addition, the expression of CDK inhibitor p27 was increased by BCH treatment in KB cells, but not CDK inhibitors p21 and p15. These results suggest that, in KB cells, the inhibition of LAT1 by BCH causes cell cycle arrest at G1 phase by inhibiting cyclin D3-CDK6 complex whereas increasing expression of a CDK inhibitor p27.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606299     DOI: 10.1248/bpb.33.1117

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.

Authors:  Tomohiro Yazawa; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Yoichi Ohtaki; Jun Atsumi; Kai Obayashi; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Izumi Takeyoshi
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

2.  Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.

Authors:  Osamu Nikkuni; Kyoichi Kaira; Minoru Toyoda; Masato Shino; Koichi Sakakura; Katsumasa Takahashi; Hideyuki Tominaga; Noboru Oriuchi; Masami Suzuki; Misa Iijima; Takayuki Asao; Masahiko Nishiyama; Shushi Nagamori; Yoshikatsu Kanai; Tetsunari Oyama; Kazuaki Chikamatsu
Journal:  Pathol Oncol Res       Date:  2015-05-30       Impact factor: 3.201

3.  Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).

Authors:  Huan-Chieh Chien; Claire Colas; Karissa Finke; Seth Springer; Laura Stoner; Arik A Zur; Brooklynn Venteicher; Jerome Campbell; Colton Hall; Andrew Flint; Evan Augustyn; Christopher Hernandez; Nathan Heeren; Logan Hansen; Abby Anthony; Justine Bauer; Dimitrios Fotiadis; Avner Schlessinger; Kathleen M Giacomini; Allen A Thomas
Journal:  J Med Chem       Date:  2018-08-10       Impact factor: 7.446

Review 4.  The role of L-type amino acid transporter 1 in human tumors.

Authors:  Yu Zhao; Lin Wang; Jihong Pan
Journal:  Intractable Rare Dis Res       Date:  2015-11

5.  ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.

Authors:  K Shimizu; K Kaira; Y Tomizawa; N Sunaga; O Kawashima; N Oriuchi; H Tominaga; S Nagamori; Y Kanai; M Yamada; T Oyama; I Takeyoshi
Journal:  Br J Cancer       Date:  2014-03-06       Impact factor: 7.640

6.  Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Authors:  M Toyoda; K Kaira; Y Ohshima; N S Ishioka; M Shino; K Sakakura; Y Takayasu; K Takahashi; H Tominaga; N Oriuchi; S Nagamori; Y Kanai; T Oyama; K Chikamatsu
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

7.  JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells.

Authors:  Dae Woo Choi; Do Kyung Kim; Yoshikatsu Kanai; Michael F Wempe; Hitoshi Endou; Jong-Keun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

8.  Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.

Authors:  Maihulan Maimaiti; Shinichi Sakamoto; Yasutaka Yamada; Masahiro Sugiura; Junryo Rii; Nobuyoshi Takeuchi; Yusuke Imamura; Tomomi Furihata; Keisuke Ando; Kosuke Higuchi; Minhui Xu; Tomokazu Sazuka; Kazuyoshi Nakamura; Atsushi Kaneda; Yoshikatsu Kanai; Natasha Kyprianou; Yuzuru Ikehara; Naohiko Anzai; Tomohiko Ichikawa
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

9.  Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.

Authors:  Kyoichi Kaira; Yutaka Sunose; Yasuhiro Ohshima; Noriko S Ishioka; Kazuhisa Arakawa; Tetsushi Ogawa; Noriaki Sunaga; Kimihiro Shimizu; Hideyuki Tominaga; Noboru Oriuchi; Hideaki Itoh; Shushi Nagamori; Yoshikatsu Kanai; Aiko Yamaguchi; Atsuki Segawa; Munenori Ide; Masatomo Mori; Tetsunari Oyama; Izumi Takeyoshi
Journal:  BMC Cancer       Date:  2013-10-16       Impact factor: 4.430

10.  Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.

Authors:  Yasuhiro Ohshima; Kyoichi Kaira; Aiko Yamaguchi; Noboru Oriuchi; Hideyuki Tominaga; Shushi Nagamori; Yoshikatsu Kanai; Takehiko Yokobori; Tatsuya Miyazaki; Takayuki Asao; Yoshito Tsushima; Hiroyuki Kuwano; Noriko S Ishioka
Journal:  Cancer Sci       Date:  2016-10-03       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.